All publications

Export 169 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sethi G, Sabin CA, Lycett S, Ragonnet-Cronin M, Edwards SG, Fearnhill E, Dunn DT, Delpech V, Phillips AN, Pillay D et al..  2012.  Phylogenetic analysis of HIV transmission among different ethnic MSM groups in the UK. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Sabin CA, Nelson M, Winston A et al..  2017.  An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. J Antimicrob Chemother.
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Tostevin A, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2015.  K65R detected more frequently in HIV-1 subtype C viruses at virological failure. Conference on Retroviruses and Opportunistic Infections (CROI) 2015.
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Tostevin A, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2015.  K65R detected more frequently in HIV-1 subtype C viruses at virological failure. International HIV Drug Resistance Workshop, 2015.
Stirrup O, Asboe D, Pozniak A, Sabin C, Gilson R, Mackie N, Dunn D, Cohort UKHIVDrug R.  2019.  Use of emtricitabine or lamivudine following detection of the M184V/I HIV-1 resistance mutation. 23rd International Workshop on HIV and Hepatitis Observational Databases.
Stirrup OT, Asboe D, Pozniak A, Sabin C, Gilson R, Mackie NE, Tostevin A, Hill T, Dunn DT, UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study.  2020.  Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation. HIV Med.
Stirrup O, Dunn D.  2018.  Novel methodology to evaluate associations between baseline characteristics, CD4 response and viral failure on first-line ART for HIV. 22nd International Workshop on HIV and Hepatitis Observational Databases.
Stirrup OT, Dunn DT.  2018.  Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.. BMC Med Res Methodol. 18(1):65.
Stirrup OT, Sabin CA, Phillips AN, Williams I, Churchill D, Tostevin A, Hill T, Dunn DT, UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study.  2019.  Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV.. J Virus Erad. 5(4):204-211.
Stirrup O, Dunn D.  2017.  Combining ambiguous nucleotide calls with longitudinal CD4 counts and viral load measurements to derive patient-specific distributions for date of HIV seroconversion. 21st International Workshop on HIV and Hepatitis Observational Databases.
Stirrup OT, Dunn DT, Tostevin A, Sabin CA, Pozniak A, Asboe D, Cox A, Orkin C, Martin F, Cane P.  2018.  Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data.. AIDS Res Ther. 15(1):11.
T
Takebe Y., Naito Y., Raghwani J., Fearnhill E, Sano T., Kusagawa S., Mbisa JL, Zhang H, Matano T., Leigh Brown A et al..  2014.  Intercontinental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan. J Virol. 88:9864-76.
TenoRes Study Group.  2016.  Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis.
Tostevin A, White E, Croxford S, Delpech V, Williams I, Dunn DT, UK HIV Drug Resistance Database.  2015.  Trends in transmitted drug resistance to HIV-1 in the UK since 2010. British HIV Association Conference (BHIVA) 2015.
Tostevin A, Stirrup OT, Mackie N, Asboe D, Pozniak A, Churchill D, Leigh Brown A, Sabin C, Smit E, Collins S et al..  2018.  Results of HIV-1 drug resistance tests performed in ART-experienced patients in the UK: patterns 2008 to 2015. BHIVA Spring.
Tostevin A, White E, Dunn DT, Croxford S, Delpech V, Williams I, Asboe D, Pozniak A, Churchill D, Geretti AM et al..  2016.  Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom. HIV Med.
U
UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study(UK CHIC), UK Register of HIV Seroconverters.  2007.  Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS. 21:1035-9.
UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study(UK CHIC).  2010.  Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy. Clin Infect Dis. 50:1275-85.
UK HIV Drug Resistance Database.  2014.  The increasing genetic diversity of HIV-1 in the UK, 2002-2010. AIDS. 28:773-80.
V
Volz E, Le Vu S, Ratmann O, Tostevin A, Delpech V, Brown A, Gill NO, Fraser C.  2017.  Phylodynamic analysis to guide allocation of Pre-Exposure Prophylaxis in the United Kingdom. 24th International HIV Dynamics and Evolution.